Arsenal acquires drug development software company; add-ons ahead

Aresnal Capital, the New York mid-market shop, this week closed the acquisition of Certara, a supplier of model-based software to biopharmaceutical companies for drug development and data analytics. Terms were not disclosed.

Managers